Ministry health

Ministry of Health grants approval for transfer of license from IHF to JUMP

Toronto, Ontario – (Newsfile Corp. – December 23, 2021) – Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) (“Leveljump” or the “Company”), a Canadian leader in B2B Telehealth Solutions, is pleased to announce that it has received approval from the Ontario Ministry of Health for the transfer, from the vendors to JUMP, of one of the three IHF (“Independent Health Facilities”) licenses previously disclosed in a press release dated September 28e, 2021. In addition, the ministry has extended the license of this IHF to include additional billing codes and procedures, which will allow the Company to offer more services to the local community as well as increase revenues from this IHF location.

The Company is awaiting approval of the two additional IHFs that have been purchased and with funding in place through TD Canada Trust, the Company is confident that the transaction will close in January 2022.

Real-time medical purchasing update

The Company has received approval from the TSX Venture Exchange for its purchase in full of the 2.3% shares of Real Time Medical, as announced in a press release dated December 17, 2021. The transaction is now complete and the Company currently owns 16.89% of Real Time. Medical society

About Leveljump Healthcare

Leveljump Healthcare Corp., (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) is a healthcare company focused on cost-effective telehealth solutions as well as primary care radiology services. The Company’s subsidiary, CTS, provides offsite x-ray readings for hospital emergency rooms and is a leader in teleradiology in Ontario. As part of our growth strategy, we are acquiring healthcare companies that have strong revenues and cash flows, with room for organic growth.


Mitchell Geisler, President and CEO
[email protected]
(833) 840-2020


This press release contains “forward-looking information” within the meaning of applicable securities laws relating to the business plans of the Company and the outlook for the Company’s industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been deemed appropriate, that the expectations reflected in this forward-looking information are reasonable, it do not place undue reliance on them because the Company cannot guarantee that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements contained in this press release are made as of the date of this press release and the Company assumes no responsibility to update or revise them to reflect new events or circumstances other than those required by securities laws. applicable movable property. The Company assumes no obligation to comment on any analyzes, expectations or statements made by third parties with respect to the Company, Canadian Teleradiology Services, Inc., their titles or their respective financial or operational results (if any).

Neither the Bourse nor its regulatory services provider (as that term is defined in the policies of the Bourse) accepts responsibility for the adequacy or accuracy of this release.

The securities offered have not been and will not be registered under the United States Securities Act of 1933, as amended (the “US Securities Act”) or any United States securities law, and may not be offered or sold in the United States. United States or to, or on behalf of or for the benefit of, persons of the United States without registration or applicable exemption from the registration requirements of the US Securities Act and applicable United States securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities in the United States or in any other jurisdiction.

To view the source version of this press release, please visit